Literature DB >> 29019617

Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go?

Bertram Pitt1, Patrick Rossignol2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29019617     DOI： 10.1093/eurheartj/ehx537

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments.

Authors:  Faiez Zannad; João Pedro Ferreira; Bertram Pitt
Journal:  Eur Heart J Suppl       Date:  2019-02-26       Impact factor: 1.803

2.  A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology.

Authors:  Patrick Rossignol
Journal:  Eur Heart J Suppl       Date:  2019-02-26       Impact factor: 1.803

3.  Use of advanced statistical techniques to predict all-cause mortality in the Systolic Blood Pressure Intervention Trial.

Authors:  William J Kostis; Javier Cabrera; Chun Pang Lin; John B Kostis; Jennifer Wellings; Stavros Zinonos; Jeanne M Dobrzynski; Daniel Blickstein
Journal:  Int J Cardiol Hypertens       Date:  2020-09-19

4.  Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer.

Authors:  Jonathan Slawik; Juliane Dederer; Ingrid Kindermann; Michael Böhm
Journal:  ESC Heart Fail       Date:  2020-06-17

5.  Serum potassium in the PARADIGM-HF trial.

Authors:  João Pedro Ferreira; Ulrik M Mogensen; Pardeep S Jhund; Akshay S Desai; Jean-Lucien Rouleau; Michael R Zile; Patrick Rossignol; Faiez Zannad; Milton Packer; Scott D Solomon; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2020-09-29       Impact factor: 15.534

6.  Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failure.

Authors:  Aldo P Maggioni; Letizia Dondi; Felicita Andreotti; Silvia Calabria; Massimo Iacoviello; Marco Gorini; Lucio Gonzini; Carlo Piccinni; Giulia Ronconi; Nello Martini
Journal:  Eur J Clin Invest       Date:  2021-03-31       Impact factor: 4.686
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.